By Dr Daniel Dawson Murray

Preprints

Marandi RZ; Frahm AS; Lundgren J; Murray DD; Milojevic M, 2025, Medical artificial intelligence toolbox (MAIT): an explainable machine learning framework for binary classification, survival modelling, and regression analyses, http://dx.doi.org/10.48550/arxiv.2501.04547

Zucco AG; Bennedbæk M; Ekenberg C; Gabrielaite M; Leung P; Polizzotto MN; Kan V; Murray DD; Lundgren JD; Macpherson CR; group TISS, Associations of functional HLA class I groups with HIV viral load in a heterogeneous cohort, http://dx.doi.org/10.1101/2022.06.21.22276431

Gelpi M; Mikaeloff F; Knudsen AD; Benfeitas R; Krishnan S; Høgh J; Murray DD; Ullum H; Neogi U; Nielsen SD, Central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome: a cross-sectional cohort study, http://dx.doi.org/10.1101/2021.04.01.21254778

Group ATBS; Lundgren JD; Grund B; Barkauskas CE; Holland TL; Gottlieb RL; Sandkovsky U; Brown SM; Knowlton KU; Self WH; Files DC; Jain MK; Benfield T; Bowdish ME; Leshnower BG; Baker JV; Jensen J-U; Gardner EM; Ginde AA; Harris ES; Johansen IS; Markowitz N; Matthay MA; Østergaard L; Chang CC; Goodman A; Chang W; Dewar RL; Gerry NP; Higgs ES; Highbarger H; Murray DD; Murray TA; Natarajan V; Paredes R; Parmar MKB; Phillips AN; Reilly C; Rupert AW; Sharma S; Shaw-Saliba K; Sherman BT; Teitelbaum M; Wentworth D; Cao H; Klekotka P; Babiker AG; Davey VJ; Gelijns AC; Kan VL; Polizzotto MN; Thompson BT; Lane HC; Neaton JD, Clinical and Virological Response to a Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19, http://dx.doi.org/10.1101/2021.07.19.21260559

Murray DD; Babiker AG; Baker JV; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3), http://dx.doi.org/10.1101/2020.11.08.20227876

Villumsen SO; Benfeitas R; Knudsen AD; Gelpi M; Høgh J; Thomsen MT; Murray D; Ullum H; Neogi U; Nielsen SD, Integrative lipidomics and metabolomics for system-level understanding of the metabolic syndrome in long-term treated HIV-infected individuals, http://dx.doi.org/10.1101/2021.05.04.21256640

Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Høgh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Trøseid M; Nielsen SD; Neogi U, Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection, http://dx.doi.org/10.1101/2022.06.08.495246

Murray JM; Murray DD; Schvoerer E; Akand EH, SARS-COV-2 Delta and Omicron community transmission networks, http://dx.doi.org/10.1101/2022.05.30.22275787

Back to profile page